Thanks for your interest in the Boehringer Ingelheim panel discussion taking place on 13 October 2022 at 19:00 (Shanghai time, GMT +8).

With the theme of "Globalising Chinese healthcare innovations", three senior BI China leaders will share their thoughts on how leading multinational companies like Boehringer Ingelheim can empower Chinese healthcare innovations to go global.

The three panelists are:

• Dr. Hongmei Li, Senior Director of Investment at the BI Venture Fund

• Yajuan Chen, Oncology R&D and Medical Affairs Lead at BI China

• Yiting Zheng, Smart Healthcare Technology Digital Innovation Consultant at BI China

Agenda: 13 October 2022, Shanghai
19:00-19:10: Introduction to Boehringer Ingelheim
19:10-19:55: Panel Discussion
19:55-20:30: Q&A

The event will take place live in Shanghai and be simultaneously broadcast via Zoom. We are offering limited opportunities to students that have already signed up for our INNOVATEChina2022 competition to attend the event live in Shanghai and network with BI executives!

Name:

Email:
(We will send the event Zoom link to your email the day before.)

Company/School/Organisation:

Have you already registered for the INNOVATEChina2022 competition and would like to attend the event offline in Shanghai?
Yes

Δ